Association of M2BPGi with Subclinical Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Choi YJ, Lee K, Cho HI, Park J, Shin MG, Lee YS, Cho S, Nah EH

Open source

DOI
10.3390/metabo16080524
Published
2026 Jul 24
Container
Metabolites
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/metabo16080524,
  title = {Association of M2BPGi with Subclinical Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.},
  author = {Choi YJ and Lee K and Cho HI and Park J and Shin MG and Lee YS and Cho S and Nah EH},
  year = {2026},
  journal = {Metabolites},
  doi = {10.3390/metabo16080524},
  url = {https://doi.org/10.3390/metabo16080524}
}

RIS

TY  - JOUR
TI  - Association of M2BPGi with Subclinical Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.
AU  - Choi YJ
AU  - Lee K
AU  - Cho HI
AU  - Park J
AU  - Shin MG
AU  - Lee YS
AU  - Cho S
AU  - Nah EH
PY  - 2026
JO  - Metabolites
DO  - 10.3390/metabo16080524
UR  - https://doi.org/10.3390/metabo16080524
ER  - 

APA

YJ, C., K, L., HI, C., J, P., MG, S., YS, L., S, C., & EH, N. (2026). Association of M2BPGi with Subclinical Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.. Metabolites. https://doi.org/10.3390/metabo16080524

Source records